The global blood based biomarker market is primarily driven by the increasing prevalence of target diseases such as cancer and cardiovascular diseases.
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |